Gregory Everson
Seminars
Tuesday 30th September 2025
4:45 pm HepQuant DuO™ Defines Risk for Clinical Outcome and Quantifies Changes in Risk
- Fully characterize the spectrum of liver health within study populations by measuring liver function and physiology
- Estimate clinical outcome from DSI and ∆DSI after a treatment intervention, using RISK ACE Score
- With functional characterization and identification of the high risk Child Pugh A patient, a smaller sample size and shorter trial duration can more efficiently achieve the endpoint of clinical outcomes in a cirrhotic trial
